The Global Antacid Market was worth USD 3,790 million in 2016 and estimated to be growing at a CAGR of 2.5%, to reach USD 4,290 million by 2021. The market is showcasing evident potential in the mentioned forecasting period. It is expected to show significant growth in coming years because of the people being habitual of indulging in poor eating habits and resultantly facing stomach problems. The number of cases of people falling sick have been rising significantly lately.
Antacid are substances used to neutralize acidity in stomach, which in turn relieves stomach upset, heartburn and indigestion. In case of excessive secretion of acids in the digestive system, the natural mucous barrier responsible for protecting the lining in the stomach can damage the oesophagus. Increasing cases of stomach problems experienced by people has led to companies gaining interest in the Antacids market recently.
Antacids directly target the excess acids and get rid of them unlike other medications which reduce or prevent stomach acid excretion. Hence it shows better results compared to other medications. Further, Antacid come either as a chewable gum, liquid or a tablet, thus being easy to use by patients across all age groups. These factors have been driving the growth of the Antacid market lately. On the other hand, there are some restraints that are faced by antacids which include certain side effects like constipation, laxative effect, and allergic reactions. Further people with certain medical conditions are prone to adverse effects worsening their health conditions like people with heart conditions may face problems due to high amount of sodium present in Antacids.
The Global market for Antacid is segmented based on submarkets, applications and ingredients. By submarkets the market is further segmented under Chromatography, E-Clinical Trial Solutions, Wireless Health, Healthcare IT outsourcing, Clinical Trial Management Systems(CTMS), Immunoassay, Digital Pathology, Next Generation sequencing(NGS), Proteomics, Antacids with Antiflatulents. By Application the market is segment into Novel dietary fibers. Coming to ingredients the market is segmented under Protease, Modified starch, Food & Beverage Starch, Gelatin, Collagen, Carbohydrase, Food & Beverage Sugars & its substitutes. Under submarket segment, Chromatography accounted for the highest share in the market followed by Clinical Trial Management Systems (CTMS). Based on Ingredients segmentation, protease leads the market share. Under geography analysis, the global market is segmented under various regions namely Europe, North America, Asia-Pacific, Latin America and MENA. The Antacid market was dominated by North America, with the overall market share of over 45% globally. North America was followed by Europe and Asia-Pacific. Asia Pacific is predicted to grow at a rapid pace in the coming few years.
Some of the major leaders for the Antacid market include First Aid Only, WellSpring Pharm, GSK, Private Lable, Pfizer, Procter & Gamble, Glaxosmithkline, Boehringer Ingellheim Pharm, Novaritis Consurmer Health, Johnson & Johnson.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: [email protected]
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases